13 results on '"Shapira SK"'
Search Results
2. State-specific prevalence of current e-cigarette use by disability status and disability type-United States, BRFSS 2016-2018.
- Author
-
Zhang QC, Courtney-Long EA, Sinclair LB, Reese S, Armour BS, and Shapira SK
- Subjects
- Adolescent, Adult, Behavioral Risk Factor Surveillance System, Cross-Sectional Studies, Humans, Population Surveillance, Prevalence, United States epidemiology, Young Adult, Disabled Persons, Electronic Nicotine Delivery Systems, Vaping epidemiology
- Abstract
Background: Cigarette smoking is the leading cause of preventable disease and death in the United States. The tobacco product landscape has diversified to include electronic cigarettes (e-cigarettes). Adults with disabilities are more likely than adults without disabilities to smoke cigarettes, but within the current body of literature, there is limited information on the use of e-cigarettes among adults with disabilities., Objective: To assess overall and state-specific prevalence of current e-cigarette use among adults by disability status, disability type, sex, and age., Methods: Disability was defined as having serious difficulty with vision, hearing, mobility, cognition, or any difficulty with self-care or independent living. The Behavioral Risk Factor Surveillance System cross-sectional survey data (2016-2018; n = 1,150,775) were used to estimate state and District of Columbia prevalence of current e-cigarette use among adults (aged ≥18 years) with and without disabilities, overall and by disability type, sex, and age group., Results: Median prevalence of current e-cigarette use was higher among adults with than without disabilities (6.5% vs. 4.3%, P < 0.05). Among adults with disabilities, use varied from 2.5% in DC to 10.0% in Colorado; median use was highest among those with cognitive disabilities (10.0%) and those aged 18-24 years (18.7%)., Conclusions: Prevalence of current e-cigarette use was higher among adults with than without disabilities and varied across states by disability status, type, and age group. The findings underscore the need to monitor e-cigarette use among adults with disabilities and specifically include them in tobacco control policies and programs addressing e-cigarette use., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
3. Infants with Congenital Disorders Identified Through Newborn Screening - United States, 2015-2017.
- Author
-
Sontag MK, Yusuf C, Grosse SD, Edelman S, Miller JI, McKasson S, Kellar-Guenther Y, Gaffney M, Hinton CF, Cuthbert C, Singh S, Ojodu J, and Shapira SK
- Subjects
- Congenital Abnormalities epidemiology, Humans, Infant, Newborn, Prevalence, United States epidemiology, Congenital Abnormalities diagnosis, Neonatal Screening
- Abstract
Newborn screening (NBS) identifies infants at risk for congenital disorders for which early intervention has been shown to improve outcomes (1). State public health programs are encouraged to screen for disorders on the national Recommended Uniform Screening Panel (RUSP), which increased from 29 disorders in 2005 to 35 in 2018.* The RUSP includes hearing loss (HL) and critical congenital heart defects, which can be detected through point-of-care screening, and 33 disorders detected through laboratory screening of dried blood spot (DBS) specimens. Numbers of cases for 33 disorders on the RUSP (32 DBS disorders and HL) reported by 50 U.S. state programs were tabulated. The three subtypes of sickle cell disease (SCD) listed as separate disorders on the RUSP (S,S disease; S,beta-thalassemia; and S,C disease) were combined for the current analysis, and the frequencies of the resulting disorders were calculated relative to annual births. During 2015-2017, the overall prevalence was 34.0 per 10,000 live births. Applying that frequency to 3,791,712 live births in 2018,
† approximately 12,900 infants are expected to be identified each year with one of the disorders included in the study. The most prevalent disorder is HL (16.5 per 10,000), and the most prevalent DBS disorders are primary congenital hypothyroidism (CH) (6.0 per 10,000), SCD (4.9 per 10,000), and cystic fibrosis (CF) (1.8 per 10,000). Notable changes in prevalence for each of these disorders have occurred since the previous estimates based on 2006 births (2). The number of infants identified at a national level highlights the effect that NBS programs are having on infant health through early detection, intervention, and potential improved health, regardless of geographic, racial/ethnic, or socioeconomic differences., Competing Interests: All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. Sari Edelman, Cynthia F. Hinton, Yvonne Kellar-Guenther, Sarah McKasson, Joshua I. Miller, Jelili Ojodu, Marci K. Sontag, Sikha Singh, and Careema Yusuf report grants from Health Resources and Services Administration during the conduct of the study. No other potential conflicts of interest were disclosed.- Published
- 2020
- Full Text
- View/download PDF
4. Relationship of Weight Outcomes, Co-Occurring Conditions, and Severity of Autism Spectrum Disorder in the Study to Explore Early Development.
- Author
-
Levy SE, Pinto-Martin JA, Bradley CB, Chittams J, Johnson SL, Pandey J, Pomykacz A, Ramirez A, Reynolds A, Rubenstein E, Schieve LA, Shapira SK, Thompson A, Young L, and Kral TVE
- Subjects
- Autism Spectrum Disorder diagnosis, Child Development Disorders, Pervasive diagnosis, Child, Preschool, Comorbidity, Cross-Sectional Studies, Female, Follow-Up Studies, Humans, Male, Prevalence, Retrospective Studies, Severity of Illness Index, United States epidemiology, Autism Spectrum Disorder epidemiology, Body Weight, Child Development, Child Development Disorders, Pervasive epidemiology, Population Surveillance methods
- Abstract
Objective: To assess contributing factors to increased obesity risk, by comparing children with autism spectrum disorder (ASD), developmental delays/disorders, and general population controls in weight status, and to examine associations between weight status and presence of co-occurring medical, behavioral, developmental, or psychiatric conditions across groups and ASD severity among children with ASD., Study Design: The Study to Explore Early Development is a multisite cross-sectional study of children, 2-5 years of age, classified as children with ASD (n = 668), children with developmental delays/disorders (n = 914), or general population controls (n = 884). Using an observational cohort design, we compared the 3 groups. Children's heights and weights were measured during a clinical visit. Co-occurring conditions (medical, behavioral, developmental/psychiatric) were derived from medical records, interviews, and questionnaires. ASD severity was measured by the Ohio State University Global Severity Scale for Autism., Results: The odds of overweight/obesity were 1.57 times (95% CI 1.24-2.00) higher in children with ASD than general population controls and 1.38 times (95% CI 1.10-1.72) higher in children with developmental delays/disorders than general population controls. The aORs were elevated for children with ASD after controlling for child co-occurring conditions (ASD vs general population controls: aOR = 1.51; 95% CI 1.14-2.00). Among children with ASD, those with severe ASD symptoms were 1.7 times (95% CI 1.1-2.8) more likely to be classified as overweight/obese compared with children with mild ASD symptoms., Conclusions: Prevention of excess weight gain in children with ASD, especially those with severe symptoms, and in children with developmental delays/disorders represents an important target for intervention., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
5. CDC Grand Rounds: Newborn Screening for Hearing Loss and Critical Congenital Heart Disease.
- Author
-
Grosse SD, Riehle-Colarusso T, Gaffney M, Mason CA, Shapira SK, Sontag MK, Braun KVN, and Iskander J
- Subjects
- Centers for Disease Control and Prevention, U.S., Early Diagnosis, Humans, Infant, Newborn, Program Evaluation, United States, Hearing Loss diagnosis, Heart Defects, Congenital diagnosis, Neonatal Screening methods, Point-of-Care Systems
- Abstract
Newborn screening is a public health program that benefits 4 million U.S. infants every year by enabling early detection of serious conditions, thus affording the opportunity for timely intervention to optimize outcomes (1). States and other U.S. jurisdictions decide whether and how to regulate newborn screening practices. Most newborn screening is done through laboratory analyses of dried bloodspot specimens collected from newborns. Point-of-care newborn screening is typically performed before discharge from the birthing facility. The Recommended Uniform Screening Panel includes two point-of-care conditions for newborn screening: hearing loss and critical congenital heart disease (CCHD). The objectives of point-of-care screening for these two conditions are early identification and intervention to improve neurodevelopment, most notably language and related skills among infants with permanent hearing loss, and to prevent death or severe disability resulting from delayed diagnosis of CCHD. Universal screening for hearing loss using otoacoustic emissions or automated auditory brainstem response was endorsed by the Joint Committee on Infant Hearing in 2000 and 2007* and was incorporated in the first Recommended Uniform Screening Panel in 2005. Screening for CCHD using pulse oximetry was recommended by the Advisory Committee on Heritable Disorders in Newborns and Children in 2010 based on an evidence review
† and was added to the Recommended Uniform Screening Panel in 2011.§ .- Published
- 2017
- Full Text
- View/download PDF
6. Single newborn screen or routine second screening for primary congenital hypothyroidism.
- Author
-
Shapira SK, Hinton CF, Held PK, Jones E, Harry Hannon W, and Ojodu J
- Subjects
- Algorithms, Congenital Hypothyroidism ethnology, Humans, Infant, Newborn, Retrospective Studies, United States epidemiology, Congenital Hypothyroidism diagnosis, Congenital Hypothyroidism epidemiology, Neonatal Screening methods
- Abstract
Routine second screening of most newborns at 8-14 days of life for a panel of newborn conditions occurs in 12 U.S. states, while newborns in the other states typically undergo only a single routine newborn screen. The study objective was to evaluate screening consequences for primary congenital hypothyroidism (CH) in one- and two-screen states according to laboratory practices and medical or biochemical characteristics of screen-positive cases. Individual-level medical and biochemical data were retrospectively collected and analyzed for 2251 primary CH cases in one-screen (CA, WI) and two-screen (AL, DE, MD, OR, TX) states. Aggregate data were collected and analyzed for medical and biochemical characteristics of all screened newborns in the states. Among the states evaluated in this study, the detection rate of primary CH was higher in the one-screen states. In the two-screen states, 11.5% of cases were detected on the second screen. In multivariate analyses, only race/ethnicity was a significant predictor of cases identified on the first versus second screen, which likely reflects a physiologic difference in primary CH presentation. Newborn screening programs must heed the potential for newborns with CH not being detected by a single screen, particularly newborns of certain races/ethnicities. If the two-screen states converted to a single screen using their current algorithms, newborns currently identified on the routine second screen would presumably not be detected, resulting in probable delayed diagnosis and treatment. However, based on the one-screen state experiences, with appropriate modifications in screening method and algorithm, the two-screen states might convert to single screen operation for CH without loss in performance., (Published by Elsevier Inc.)
- Published
- 2015
- Full Text
- View/download PDF
7. Congenital adrenal hyperplasia cases identified by newborn screening in one- and two-screen states.
- Author
-
Held PK, Shapira SK, Hinton CF, Jones E, Hannon WH, and Ojodu J
- Subjects
- Algorithms, Female, Humans, Infant, Infant, Newborn, Male, Retrospective Studies, United States epidemiology, Adrenal Hyperplasia, Congenital diagnosis, Adrenal Hyperplasia, Congenital epidemiology, Neonatal Screening methods
- Abstract
There is no clear consensus among state newborn screening programs on whether routine second screening of newborns identifies clinically relevant cases of congenital adrenal hyperplasia. This retrospective study evaluated laboratory practices, along with biochemical and medical characteristics of congenital adrenal hyperplasia (CAH) cases (1) detected on the first newborn screen in one-screen compared to two-screen states, and (2) detected on the first versus the second screen in the two-screen states, to determine the effectiveness of a second screen. A total of 374 confirmed cases of CAH from 2 one-screen states and 5 two-screen states were included in this study. Demographic data and diagnostic information on each reported case were collected and analyzed. Additionally, laboratory data, including screening methodologies and algorithms, were evaluated. The one-screen states reported 99 cases of CAH out of 1,740,586 (1 in 17,500) newborns screened: 88 (89%) identified on the first screen and 5 (5%) identified on the targeted second screen. The two-screen states reported 275 cases of CAH out of 2,629,627 (1 in 9500) newborns screened: 165 (60%) identified on the first screen and 99 (36%) identified on the second screen. Using a multivariate model, the only significant predictor of whether a case was identified on the first or the second screen in the two-screen states was the type of CAH. Compared with classical salt-wasting CAH, classical simple virilizing and non-classical CAH cases were less likely to be detected on the first versus the second screen. The routine second newborn screen is important for identifying children with CAH, particularly simple virilizing and non-classical forms, which might otherwise not be captured through a single screen., (Copyright © 2015 Elsevier Inc. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
8. The National Birth Defects Prevention Study: A review of the methods.
- Author
-
Reefhuis J, Gilboa SM, Anderka M, Browne ML, Feldkamp ML, Hobbs CA, Jenkins MM, Langlois PH, Newsome KB, Olshan AF, Romitti PA, Shapira SK, Shaw GM, Tinker SC, and Honein MA
- Subjects
- Congenital Abnormalities epidemiology, Female, Genetic Predisposition to Disease, Humans, Infant, Newborn, United States epidemiology, Congenital Abnormalities prevention & control, Data Collection methods, Genetic Markers, Neonatal Screening methods, Population Surveillance methods
- Abstract
Background: The National Birth Defects Prevention Study (NBDPS) is a large population-based multicenter case-control study of major birth defects in the United States., Methods: Data collection took place from 1998 through 2013 on pregnancies ending between October 1997 and December 2011. Cases could be live born, stillborn, or induced terminations, and were identified from birth defects surveillance programs in Arkansas, California, Georgia, Iowa, Massachusetts, New Jersey, New York, North Carolina, Texas, and Utah. Controls were live born infants without major birth defects identified from the same geographical regions and time periods as cases by means of either vital records or birth hospitals. Computer-assisted telephone interviews were completed with women between 6 weeks and 24 months after the estimated date of delivery. After completion of interviews, families received buccal cell collection kits for the mother, father, and infant (if living)., Results: There were 47,832 eligible cases and 18,272 eligible controls. Among these, 32,187 (67%) and 11,814 (65%), respectively, provided interview information about their pregnancies. Buccal cell collection kits with a cytobrush for at least one family member were returned by 19,065 case and 6,211 control families (65% and 59% of those who were sent a kit). More than 500 projects have been proposed by the collaborators and over 200 manuscripts published using data from the NBDPS through December 2014., Conclusion: The NBDPS has made substantial contributions to the field of birth defects epidemiology through its rigorous design, including case classification, detailed questionnaire and specimen collection, large study population, and collaborative activities across Centers., (© 2015 Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
9. Rationale for periodic reporting on the use of selected clinical preventive services to improve the health of infants, children, and adolescents--United States.
- Author
-
Yeung LF, Shapira SK, Coates RJ, Shaw FE, Moore CA, Boyle CA, and Thacker SB
- Subjects
- Adolescent, Centers for Disease Control and Prevention, U.S., Child, Female, Humans, Infant, Male, United States, Adolescent Health Services statistics & numerical data, Child Health Services statistics & numerical data, Population Surveillance, Preventive Health Services statistics & numerical data
- Abstract
This supplement is the second of a series of periodic reports from a CDC initiative to monitor and report on the use of a set of selected clinical preventive services in the U.S. population in the context of recent national initiatives to improve access to and use of such services. Increasing the use of these services can result in substantial reductions in the burden of illness, death, and disability and lower treatment costs. This supplement focuses on services to improve the health of U.S. infants, children, and adolescents. The majority of clinical preventive services for infants, children, and adolescents are provided by the health-care sector. Public health agencies play important roles in increasing the use of these services by identifying and implementing policies that are effective in increasing use of the services and by collaborating with stakeholders to conduct programs to improve use. Recent health-reform initiatives, including efforts to increase the accessibility and affordability of preventive services, fund community prevention programs, and improve the use of health information technologies, offer opportunities to improve use of preventive services. This supplement, which follows a previous report on adult services, provides baseline information on the use of a set of selected clinical preventive services to improve the health of infants, children, and adolescents before implementation of these recent initiatives and discusses opportunities to increase the use of such services. This information can help public health practitioners, in collaboration with other stakeholders that have key roles in improving infant, child, and adolescent health (e.g., parents or guardians and their employers, health plans, health professionals, schools, child care facilities, community groups, and voluntary associations), understand the potential benefits of the recommended services, address the problem of underuse, and identify opportunities to apply effective strategies to improve use and foster accountability among stakeholders.
- Published
- 2014
10. Birth prevalence rates of newborn screening disorders in relation to screening practices in the United States.
- Author
-
Hertzberg VS, Hinton CF, Therrell BL, and Shapira SK
- Subjects
- Chromatography, High Pressure Liquid, Enzyme-Linked Immunosorbent Assay, Fluoroimmunoassay, Humans, Infant, Newborn, Neonatal Screening methods, Prevalence, Tandem Mass Spectrometry, United States, Adrenal Hyperplasia, Congenital epidemiology, Anemia, Sickle Cell epidemiology, Phenylketonurias epidemiology
- Abstract
Objective: To examine the associations between the first-tier-screening laboratory methods and criteria and the birth prevalence of congenital adrenal hyperplasia (CAH), phenylketonuria (PKU), and the sickle hemoglobinopathies occurring in the United States between 1991 and 2000., Study Design: By using validated data from the National Newborn Screening and Genetics Resource Center, we fit Poisson regression models with laboratory methods and criteria used in every year for each state for each disorder. We also examined whether there was an overall change in birth prevalence over the decade and whether there was an effect resulting from obligatory second screenings., Results: There were no associations among any of the factors and the birth prevalence of PKU in this decade. Use of the enzyme-linked immunosorbent assay was more likely than any other laboratory method to identify cases of CAH (OR 1.16; 95% CI 1.04-1.30), but no other factors were associated with this disorder. None of the factors examined were associated with the birth prevalence rates of any of the sickle hemoglobinopathies., Conclusion: There were no substantial changes in the birth prevalence rates of PKU, CAH, or the sickle hemoglobinopathies over the study period despite rapid changes in technology., (Copyright © 2011 Mosby, Inc. All rights reserved.)
- Published
- 2011
- Full Text
- View/download PDF
11. Letter to the editor: Ventricular septal defects and the National Birth Defects Prevention Study.
- Author
-
Rasmussen SA, Riehle-Colarusso T, Shapira SK, Honein MA, and Reefhuis J
- Subjects
- Congenital Abnormalities epidemiology, Congenital Abnormalities prevention & control, Female, Heart Septal Defects, Ventricular epidemiology, Heart Septal Defects, Ventricular prevention & control, Humans, Infant, Newborn, Population Surveillance methods, United States epidemiology, Centers for Disease Control and Prevention, U.S. classification, Congenital Abnormalities classification, Heart Septal Defects, Ventricular classification, Heart Septal Defects, Ventricular physiopathology
- Published
- 2011
- Full Text
- View/download PDF
12. Future research directions to identify causes of the increasing incidence rate of congenital hypothyroidism in the United States.
- Author
-
Shapira SK, Lloyd-Puryear MA, and Boyle C
- Subjects
- Biomedical Research, Birth Weight, Congenital Hypothyroidism diagnosis, Congresses as Topic, Female, Humans, Incidence, Infant, Newborn, Neonatal Screening, Parity, Pregnancy, Premature Birth epidemiology, Risk Factors, Thyroid Function Tests, United States, Congenital Hypothyroidism epidemiology
- Abstract
A workshop to evaluate the reported increasing trend in the incidence rate of primary congenital hypothyroidism (CH) identified by newborn screening was held February 27 and 28, 2008, in Atlanta, Georgia, and was sponsored by the Centers for Disease Control and Prevention, the Health Resources and Services Administration, and the National Newborn Screening and Genetics Resource Center. Through a series of presentations and discussions, this group of experts considered a variety of factors that could be contributing to the perceived increasing trend of the CH-incidence rate, the gaps in knowledge that need to be overcome to identify the causes of the observed trend, and possible future research activities that might resolve the uncertainties surrounding the increasing incidence rate of CH in the United States. On the basis of these discussions, workshop participants concluded that the initial focus of future efforts should be to determine if the increasing CH-incidence rate persists once there is standardization of the diagnostic criteria for the classification of CH versus transient hypothyroidism. In discussions, workshop participants suggested that if the increasing incidence rate of CH could not be explained by definitional issues, then future research could focus on the identification and evaluation of risk factors for CH that might be changing among the US population and, thus, contributing to the observed increasing incidence rate of CH.
- Published
- 2010
- Full Text
- View/download PDF
13. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004.
- Author
-
Green RF, Devine O, Crider KS, Olney RS, Archer N, Olshan AF, and Shapira SK
- Subjects
- Adult, Chromosome Aberrations, Congenital Abnormalities genetics, Congenital Abnormalities prevention & control, DNA Damage, Female, Humans, Infant, Newborn, Logistic Models, Male, Maternal Age, Odds Ratio, Registries, Risk Factors, Spermatozoa pathology, United States epidemiology, Young Adult, Congenital Abnormalities epidemiology, Paternal Age
- Abstract
Purpose: The objective of this study was to examine the associations between paternal age and birth defects of unknown etiologies while carefully controlling for maternal age., Methods: By using 1997 to 2004 data from the National Birth Defects Prevention Study, we fit logistic regression models with paternal and maternal age as continuous variables while adjusting for demographic and other factors., Results: Elevated odds ratios (ORs) for each year increase in paternal age were found for cleft palate (OR. 1.02, 95% confidence interval [95% CI], 1.00-1.04), diaphragmatic hernia (OR, 1.04; 95% CI, 1.02-1.06), right ventricular outflow tract obstruction (OR, 1.03; 95% CI, 1.01-1.04), and pulmonary valve stenosis (OR, 1.02, 95% CI, 1.01-1.04). At younger paternal ages, each year increase in paternal age correlated with increased odds of having offspring with encephalocele, cataract, esophageal atresia, anomalous pulmonary venous return, and coarctation of the aorta, but these increased odds were not observed at older paternal ages. The effect of paternal age was modified by maternal age for gastroschisis, omphalocele, spina bifida, all orofacial clefts, and septal heart defects., Conclusions: Our findings suggest that paternal age may be a risk factor for some multifactorial birth defects., (Published by Elsevier Inc.)
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.